Singapore: Cancer is the biggest cause of mortality worldwide as the killer disease claimed an estimated 8.2 million liv...
Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collab...
Singapore: National Institute of Health and Clinical Excellence (NICE) has decided to recommend Bristol-Myers Squibb's Y...
Singapore: National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Departme...
Singapore: Singapore-based TauRx Pharmaceuticals recieved equity investment of $10.5 million from Toronto's Dundee Corpo...
Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatme...
Singapore: The National Institutes of Health (NIH), US, has launched three projects that will focus on development of t...
Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 t...
Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collabo...
Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. P...
Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and...
Singapore: Bayer HealthCare started enrolling patients in an international phase II/III trial called PROTECT VIII that i...
‎Singapore: China based pharmaceutical company, Yabao Pharmaceutical, has partnered with Eli Lilly to co-develop L...
‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to ...
Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients f...
Singapore: By scouring the DNA of thousands of patients, researchers at Broad Institute, Massachusetts General Hospital,...
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...
‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, r...
